2025
SJR Q2
JCR Q2 · 2,4
10 matched articles
SCIE
Journal detail
Toxicologic Pathology
- Publisher
- SAGE Publications Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0192623315331601
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,572
- Quartile Q2
- H-Index 134
- Cites/doc 2,55
- Docs (3y) 150
- Cites (3y) 381
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,4
- 5Y JIF 2,4
- JCI 0,64
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cell Biology Q3
- Molecular Biology Q3
- Pathology and Forensic Medicine Q2
- Toxicology Q3
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pathology | Toxicology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,572 | 2,4 | 2,4 | 0,64 | Q3 | 134 |
| 2024 | Q2 | Q3 | 0,545 | 1,8 | 1,8 | 0,59 | Q3 | 129 |
| 2023 | Q2 | Q3 | 0,575 | 1,4 | 1,9 | 0,5 | Q3 | 129 |
| 2022 | Q2 | Q4 | 0,532 | 1,5 | 2 | 0,49 | Q3 | 129 |
| 2021 | Q2 | Q4 | 0,629 | 1,9 | 2,4 | 0,53 | Q3 | 129 |
| 2020 | Q2 | Q4 | 0,613 | 1,9 | 2,4 | 0,49 | Q3 | 129 |
| 2019 | Q2 | Q3 | 0,63 | 1,5 | 1,9 | 0,56 | Q3 | 129 |
| 2018 | — | Q3 | — | 1,4 | 1,9 | 0,64 | Q3 | — |
| 2017 | Q2 | Q3 | 0,807 | 2 | 2,4 | 0,76 | Q2 | 129 |
| 2016 | Q1 | Q2 | 0,886 | 2,1 | 2,4 | — | — | 129 |
| 2015 | Q1 | Q2 | 1,08 | 2,2 | 2,5 | — | — | 129 |
| 2014 | Q2 | Q2 | 0,893 | 2,1 | 2,4 | — | — | 129 |
| 2013 | Q2 | Q3 | 0,894 | 1,9 | 2,5 | — | — | 129 |
| 2012 | Q2 | Q2 | 0,874 | 2,1 | 2,8 | — | — | 129 |
| 2011 | Q2 | Q2 | 0,869 | 1,9 | 2,6 | — | — | 129 |
| 2010 | Q2 | Q2 | 0,915 | 2,2 | 2,5 | — | — | 129 |
| 2009 | — | Q2 | — | 2,5 | 2,5 | — | — | — |
| 2008 | — | Q3 | — | 1,6 | 2 | — | — | — |
| 2007 | — | Q2 | — | 1,9 | 2,1 | — | — | — |
| 2006 | — | Q2 | — | 2,1 | — | — | — | — |
| 2005 | — | Q2 | — | 2 | — | — | — | — |
| 2004 | — | Q2 | — | 1,8 | — | — | — | — |
| 2003 | — | Q3 | — | 1,2 | — | — | — | — |
| 2002 | — | Q2 | — | 1,4 | — | — | — | — |
| 2001 | — | Q2 | — | 1,5 | — | — | — | — |
| 2000 | — | Q1 | — | 2,3 | — | — | — | — |
| 1999 | — | Q2 | — | 1,3 | — | — | — | — |
| 1998 | — | Q2 | — | 1,2 | — | — | — | — |
| 1997 | — | Q2 | — | 1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PATHOLOGY | SCIE | Q2 | Q3 | 40/89 |
| 2025 | TOXICOLOGY | SCIE | Q3 | Q3 | 74/106 |
| 2024 | PATHOLOGY | SCIE | Q3 | Q3 | 51/90 |
| 2024 | TOXICOLOGY | SCIE | Q4 | Q3 | 87/106 |
| 2023 | PATHOLOGY | SCIE | Q3 | Q3 | 60/88 |
| 2023 | TOXICOLOGY | SCIE | Q4 | Q4 | 95/106 |
| 2022 | PATHOLOGY | SCIE | Q4 | Q3 | 59/76 |
| 2022 | TOXICOLOGY | SCIE | Q4 | Q4 | 91/94 |
| 2021 | PATHOLOGY | SCIE | Q4 | Q3 | 59/77 |
| 2021 | TOXICOLOGY | SCIE | Q4 | Q4 | 86/94 |
| 2020 | PATHOLOGY | SCIE | Q4 | Q3 | 58/77 |
| 2020 | TOXICOLOGY | SCIE | Q4 | Q4 | 86/93 |
| 2019 | PATHOLOGY | SCIE | Q3 | Q3 | 56/78 |
| 2019 | TOXICOLOGY | SCIE | Q4 | Q4 | 84/92 |
| 2018 | PATHOLOGY | SCIE | Q3 | Q3 | 56/76 |
| 2018 | TOXICOLOGY | SCIE | Q4 | Q3 | 85/93 |
| 2017 | PATHOLOGY | SCIE | Q3 | Q2 | 41/79 |
| 2017 | TOXICOLOGY | SCIE | Q3 | Q3 | 65/94 |
| 2016 | PATHOLOGY | SCIE | Q2 | — | 33/79 |
| 2016 | TOXICOLOGY | SCIE | Q3 | — | 54/92 |
| 2015 | PATHOLOGY | SCIE | Q2 | — | 28/79 |
| 2015 | TOXICOLOGY | SCIE | Q3 | — | 49/90 |
| 2014 | PATHOLOGY | SCIE | Q2 | — | 32/76 |
| 2014 | TOXICOLOGY | SCIE | Q3 | — | 51/88 |
| 2013 | PATHOLOGY | SCIE | Q3 | — | 42/76 |
| 2013 | TOXICOLOGY | SCIE | Q3 | — | 60/87 |
| 2012 | PATHOLOGY | SCIE | Q2 | — | 36/77 |
| 2012 | TOXICOLOGY | SCIE | Q3 | — | 53/85 |
| 2011 | PATHOLOGY | SCIE | Q2 | — | 38/79 |
| 2011 | TOXICOLOGY | SCIE | Q3 | — | 55/83 |
| 2010 | PATHOLOGY | SCIE | Q2 | — | 31/76 |
| 2010 | TOXICOLOGY | SCIE | Q3 | — | 46/83 |
| 2009 | PATHOLOGY | SCIE | Q2 | — | 24/71 |
| 2009 | TOXICOLOGY | SCIE | Q2 | — | 31/77 |
| 2008 | PATHOLOGY | SCIE | Q3 | — | 39/69 |
| 2008 | TOXICOLOGY | SCIE | Q3 | — | 53/75 |
| 2007 | PATHOLOGY | SCIE | Q2 | — | 28/66 |
| 2007 | TOXICOLOGY | SCIE | Q3 | — | 40/73 |
| 2006 | PATHOLOGY | SCIE | Q2 | — | 26/64 |
| 2006 | TOXICOLOGY | SCIE | Q2 | — | 30/76 |
| 2005 | PATHOLOGY | SCIE | Q2 | — | 29/66 |
| 2005 | TOXICOLOGY | SCIE | Q2 | — | 26/75 |
| 2004 | PATHOLOGY | SCIE | Q2 | — | 22/65 |
| 2004 | TOXICOLOGY | SCIE | Q2 | — | 31/75 |
| 2003 | PATHOLOGY | SCIE | Q3 | — | 37/64 |
| 2003 | TOXICOLOGY | SCIE | Q3 | — | 52/77 |
| 2002 | PATHOLOGY | SCIE | Q2 | — | 32/64 |
| 2002 | TOXICOLOGY | SCIE | Q2 | — | 38/76 |
| 2001 | PATHOLOGY | SCIE | Q2 | — | 24/66 |
| 2001 | TOXICOLOGY | SCIE | Q2 | — | 32/78 |
| 2000 | PATHOLOGY | SCIE | Q1 | — | 15/67 |
| 2000 | TOXICOLOGY | SCIE | Q1 | — | 11/77 |
| 1999 | PATHOLOGY | SCIE | Q2 | — | 27/66 |
| 1999 | TOXICOLOGY | SCIE | Q2 | — | 30/74 |
| 1998 | PATHOLOGY | SCIE | Q2 | — | 27/68 |
| 1998 | TOXICOLOGY | SCIE | Q2 | — | 33/71 |
| 1997 | PATHOLOGY | SCIE | Q2 | — | 33/66 |
| 1997 | TOXICOLOGY | SCIE | Q3 | — | 32/63 |